NASDAQ:MOBI

Mobia Medical Drops Back Under IPO as Investors Question Stroke Device Plan
····

Mobia Medical Drops Back Under IPO as Investors Question Stroke Device Plan

Mobia Medical shares fell about 2% to $12.84 on Monday, remaining below their $15 IPO price less than a month after debuting on Nasdaq. The company reported first-quarter revenue of up to $12.1 million but projected a net loss of up to $18.1 million. Mobia is promoting its FDA-approved Vivistim device for stroke rehab amid rising operating costs and slow market adoption.
June 1, 2026

Stock Market Today

  • Wise Faces Investigation Over Alleged Money Laundering Controls in Europe
    June 1, 2026, 1:50 PM EDT. UK-based money transfer company Wise is under investigation by Belgian prosecutors over alleged money laundering control failures in its European operations, not its UK business. The probe focuses on suspicions that Wise accounts facilitated around €500 million in suspicious transactions across 30 European countries. Wise, which recently shifted its primary stock listing to the US Nasdaq, stated it is cooperating fully but has not received any formal findings yet. Shares plunged 17.5%, wiping more than £1 billion off its market value. The investigation could affect customer trust and lead to regulatory penalties if oversight lapses are confirmed. Founded in 2011, Wise serves over 19 million customers globally with 4.7 million daily transactions.